BMJ  2005;330:385 (19 February), doi:10.1136/bmj.330.7488.385

Paper

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

¹ Department of Social Medicine, University of Bristol, Bristol BS8 2PR, ² Wolfson Institute of Preventive Medicine, Queen Mary, University of London, London EC1M 6BQ

Objective To investigate whether selective serotonin reuptake inhibitor (SSRI) antidepressants are associated with an increased risk of suicide related outcomes in adults.

Design Meta-analysis of randomised controlled trials of SSRIs compared with placebo in adults submitted by pharmaceutical companies to the safety review of the Medicines and Healthcare products Regulatory Agency (MHRA).

Participants Over 40 000 individuals participating in 477 randomised controlled trials.

Main outcome measures Suicide, non-fatal self harm, and suicidal thoughts.

Results An estimated 16 suicides, 172 episodes of non-fatal self harm, and 177 episodes of suicidal thoughts were reported. We found no evidence that SSRIs increased the risk of suicide, but important protective or hazardous effects cannot be excluded (odds ratio 0.85, 95% credible interval 0.20 to 3.40). We found weak evidence of an increased risk of self harm (1.57, 0.99 to 2.55). Risk estimates for suicidal thoughts were compatible with a modest protective or adverse effect (0.77, 0.37 to 1.55). The relative frequency of reported self harm and suicidal thoughts in the trials compared with suicide indicates non-fatal end points were under-recorded.

Conclusion Increased risks of suicide and self harm caused by SSRIs cannot be ruled out, but larger trials with longer follow up are required to assess the balance of risks and benefits fully. Any such risks should be balanced against the effectiveness of SSRIs in treating depression. When prescribing SSRIs, clinicians should warn patients of the possible risk of suicidal behaviour and monitor patients closely in the early stages of treatment.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Audit identifies the most read BMJ research papers

Susan Mayor
BMJ 2007 334: 554-555. [Extract] [Full Text] [PDF]

Venlafaxine for major depression

Andrea Cipriani, John R Geddes, and Corrado Barbui
BMJ 2007 334: 215-216. [Extract] [Full Text] [PDF]

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study

Annalisa Rubino, Neil Roskell, Pat Tennis, Daniel Mines, Scott Weich, and Elizabeth Andrews
BMJ 2007 334: 242. [Abstract] [Full Text] [PDF]

Did regulators fail over selective serotonin reuptake inhibitors?

David Healy
BMJ 2006 333: 92-95. [Full Text] [PDF]

Suicidal behaviour and SSRIs: updated meta-analysis

Julia Saperia, Deborah Ashby, and David Gunnell
BMJ 2006 332: 1453. [Extract] [Full Text]

Do selective serotonin reuptake inhibitors cause suicide?: Risk of suicide should be assessed for whole class of antidepressants

François Curtin and Pierre Schulz
BMJ 2005 330: 1148. [Extract] [Full Text] [PDF]

Do selective serotonin reuptake inhibitors cause suicide?: Figures look doubtful

David Healy
BMJ 2005 330: 1148. [Extract] [Full Text]

Do selective serotonin reuptake inhibitors cause suicide?: Let's keep it in perspective

Isaac Sakinofsky and David L Streiner
BMJ 2005 330: 1149. [Extract] [Full Text]

SSRIs and suicide: drug companies' trials are inconclusive
BMJ 2005 330: 0. [Full Text]

Pills, thrills, and bellyaches

Kamran Abbasi
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

Suicide, depression, and antidepressants

Andrea Cipriani, Corrado Barbui, and John R Geddes
BMJ 2005 330: 373-374. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Barbui, C. MD, Esposito, E. MD, Cipriani, A. MD (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 180: 291-297 [Abstract] [Full text]  
• John-Smith, P. S., Michael, A., Davies, T. (2009). Coping with a coroner's inquest: a psychiatrist's guide. Adv. Psychiatr. Treat. 15: 7-16 [Abstract] [Full text]  
• Qaseem, A., Snow, V., Denberg, T. D., Forciea, M. A., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2008). Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED 149: 725-733 [Abstract] [Full text]  
• Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., Lohr, K. N. (2008). Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians. ANN INTERN MED 149: 734-750 [Abstract] [Full text]  
• Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L, Lewis, G, Matthews, K, McAllister-Williams, R., Peveler, R., Scott, J, Tylee, A (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22: 343-396 [Abstract]  
• Erlangsen, A, Canudas-Romo, V, Conwell, Y (2008). Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data. J. Epidemiol. Community Health 62: 448-454 [Abstract] [Full text]  
• Olfson, M., Marcus, S. C., Druss, B. G. (2008). Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample. Arch Gen Psychiatry 65: 94-101 [Abstract] [Full text]  
• Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Mann, J. J. (2007). Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets. Am. J. Psychiatry 164: 1044-1049 [Abstract] [Full text]  
• Crawford, M J, Kumar, P (2007). Intervention following deliberate self-harm: enough evidence to act?. Evid. Based Ment. Health 10: 37-39 [Full text]  
• Mukamal, K. J., Kawachi, I., Miller, M., Rimm, E. B. (2007). Body Mass Index and Risk of Suicide Among Men. Arch Intern Med 167: 468-475 [Abstract] [Full text]  
• Gaynes, B. N., Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Balasubramani, G. K., Spencer, D. C., Petersen, T., Klinkman, M., Warden, D., Nicholas, L., Fava, M. (2007). Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis. Ann Fam Med 5: 126-134 [Abstract] [Full text]  
• Cipriani, A., Geddes, J. R, Barbui, C. (2007). Venlafaxine for major depression. BMJ 334: 215-216 [Full text]  
• Rubino, A., Roskell, N., Tennis, P., Mines, D., Weich, S., Andrews, E. (2007). Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study. BMJ 334: 242-242 [Abstract] [Full text]  
• Tiihonen, J., Lonnqvist, J., Wahlbeck, K., Klaukka, T., Tanskanen, A., Haukka, J. (2006). Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort. Arch Gen Psychiatry 63: 1358-1367 [Abstract] [Full text]  
• Simon, G. E. (2006). How Can We Know Whether Antidepressants Increase Suicide Risk?. Am. J. Psychiatry 163: 1861-1863 [Full text]  
• DUBICKA, B., HADLEY, S., ROBERTS, C. (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis. Br. J. Psychiatry 189: 393-398 [Abstract] [Full text]  
• (2006). Bibliography PSYCHOPHARMACOLOGY. Focus 4: 512- [Full text]  
• (2006). Abstracts PSYCHOPHARMACOLOGY. Focus 4: 515- [Full text]  
• Ebmeier, K. P (2006). No apparent difference in suicide risk between older and newer antidepressants although older drugs may increase risk of suicide attempt during the first month of treatment.. Evid. Based Ment. Health 9: 82-82 [Full text]  
• Olfson, M., Marcus, S. C., Shaffer, D. (2006). Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.. Arch Gen Psychiatry 63: 865-872 [Abstract] [Full text]  
• Healy, D. (2006). Did regulators fail over selective serotonin reuptake inhibitors?. BMJ 333: 92-95 [Full text]  
• Blier, P. (2006). Media pressure and patient care. J Psychopharmacol 20: 469-470  
• McHenry, L (2006). Ethical issues in psychopharmacology.. J. Med. Ethics 32: 405-410 [Abstract] [Full text]  
• Saperia, J., Ashby, D., Gunnell, D. (2006). Suicidal behaviour and SSRIs: updated meta-analysis.. BMJ 332: 1453-1453 [Full text]  
• Juurlink, D. N., Mamdani, M. M., Kopp, A., Redelmeier, D. A. (2006). The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly. Am. J. Psychiatry 163: 813-821 [Abstract] [Full text]  
• RESELAND, S., BRAY, I., GUNNELL, D. (2006). Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br. J. Psychiatry 188: 354-358 [Abstract] [Full text]  
• Piaggio, G., Elbourne, D. R., Altman, D. G., Pocock, S. J., Evans, S. J. W., for the CONSORT Group, (2006). Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement. JAMA 295: 1152-1160 [Abstract] [Full text]  
• Baldessarini, R. J., Pompili, M., Tondo, L. (2006). Suicidal risk in antidepressant drug trials.. Arch Gen Psychiatry 63: 246-248 [Full text]  
• Mann, J. J., Apter, A., Bertolote, J., Beautrais, A., Currier, D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., Marusic, A., Mehlum, L., Patton, G., Phillips, M., Rutz, W., Rihmer, Z., Schmidtke, A., Shaffer, D., Silverman, M., Takahashi, Y., Varnik, A., Wasserman, D., Yip, P., Hendin, H. (2005). Suicide Prevention Strategies: A Systematic Review. JAMA 294: 2064-2074 [Abstract] [Full text]  
• Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., Carey, T. S. (2005). Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder. ANN INTERN MED 143: 415-426 [Abstract] [Full text]  
• Leslie, L. K., Newman, T. B., Chesney, P. J., Perrin, J. M. (2005). The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients. Pediatrics 116: 195-204 [Abstract] [Full text]  
• Chou, R., Helfand, M. (2005). Challenges in Systematic Reviews That Assess Treatment Harms. ANN INTERN MED 142: 1090-1099 [Abstract] [Full text]  
• (2005). From the Library. Br. J. Ophthalmol. 89: 788-788 [Full text]  
• Curtin, F., Schulz, P. (2005). Do selective serotonin reuptake inhibitors cause suicide?: Risk of suicide should be assessed for whole class of antidepressants. BMJ 330: 1148-1148 [Full text]  
• Healy, D. (2005). Do selective serotonin reuptake inhibitors cause suicide?: Figures look doubtful. BMJ 330: 1148-1148 [Full text]  
• Sakinofsky, I., Streiner, D. L (2005). Do selective serotonin reuptake inhibitors cause suicide?: Let's keep it in perspective. BMJ 330: 1149-1149 [Full text]  
• Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., Franks, P. (2005). Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial. JAMA 293: 1995-2002 [Abstract] [Full text]  
• (2005). Do SSRIs Increase Suicide Risk in Adults?. Journal Watch Dermatology 2005: 10-10 [Full text]  
• (2005). Antidepressants, Adults, and Suicidality. JWatch Women's Health 2005: 7-7 [Full text]  
• (2005). Do SSRIs Increase Suicide Risk in Adults?. JWatch General 2005: 6-6 [Full text]  
• (2005). SSRIs and Suicide Risk: A Concern for Adults, Too?. JWatch Psychiatry 2005: 1-1 [Full text]  
• Cipriani, A., Barbui, C., Geddes, J. R (2005). Suicide, depression, and antidepressants. BMJ 330: 373-374 [Full text]  

Rapid Responses:

Read all Rapid Responses

Risk of Suicide

David T Healy
bmj.com, 18 Feb 2005 [Full text]

An important methodology problem

Alexander M Ponizovsky
bmj.com, 22 Feb 2005 [Full text]

Suicide and antidepressants: a comment

Francois Curtin, et al.
bmj.com, 25 Feb 2005 [Full text]

Is reduced dopaminergic function a forgotten factor in suicidality associated with SSRIs?

Paul N Deslandes
bmj.com, 28 Feb 2005 [Full text]

Response to Professor David Healy's correspondence (18 February 2005)

David J Gunnell, et al.
bmj.com, 23 Mar 2005 [Full text]

Is drug company data suitable for investigation of risk of suicide associated with SSRIs ?

ARUNRAJ BALAKRISHNA KAIMAL, et al.
bmj.com, 31 Mar 2005 [Full text]

Suicidal behaviour and SSRIs - updated meta-analysis

Julia Saperia, et al.
bmj.com, 2 Jun 2006 [Full text]

Online poll

Find out more >>